Opal Therapeutics' Series A Round

Opal Therapeutics raised a round of funding on February 19, 2005.

Opal Therapeutics is an immunotherapy company focused on novel therapies for human immunodeficiency virus (HIV) and Hepatitis C (HCV), based on technology from the University of Melbourne.…

Articles about Opal Therapeutics' Series A Round: